Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Number To Know…18

Executive Summary

Israel boasts 18 hi-tech incubators, designed to nurture start-ups and maintain the country’s well-recognized position as a medtech innovation generator.

The Israeli government's hi-tech incubator program, one of the key sources of funding for the country’s start-ups, was founded in 1991 and today there are 18 incubators in total, all of which have been privatized. The incubators function as a center for entrepreneurship and nurture companies from seed to early stage, thereby minimizing the risk to future investors. They also offer a supportive framework for the establishment of a company and development of a concept into a commercial product, with many companies’ R&D facilities based at the incubator.

To gain more insight into Israel’s incubators, the venture funding landscape, where the players see the opportunities are for Israeli innovation, read Medtech Insight’s article here.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT104544

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel